文献速递精神分裂症与精神病性障碍

炎症生物标志物与精神分裂症风险:两样本孟德尔随机化研究

Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study.
PubMed 文献 · JAMA Psychiatry · 2017-01-01

该两样本孟德尔随机化研究利用炎症生物标志物的遗传工具变量评估其对精神分裂症风险的因果效应。

要点

  • 遗传预测的CRP水平升高与精神分裂症风险降低相关。
  • 遗传预测的sIL-6R水平升高与精神分裂症风险轻度增加相关。
  • IL-1Ra的孟德尔随机化估计不精确,未发现明确效应。

核心结论

  • 在孟德尔随机化假设下,CRP对精神分裂症风险具有保护效应,sIL-6R具有风险增加效应,后者可能部分由CRP介导。

研究设计与样本

  • 两样本孟德尔随机化研究,使用与炎症生物标志物相关的遗传变异作为工具变量。
  • 多数研究参与者为欧洲 ancestry,男性比例约50%,均为成年人,年龄范围18至80岁。

主要发现

  • 使用不同孟德尔随机化方法和更保守的工具变量集获得一致结果。
  • IL-1Ra的估计在不同工具变量间不一致,合并估计不精确且以零为中心。

关键数值与推荐

  • IL-1Ra合并估计不精确且以零为中心,未报告具体数值。

临床怎么用

  • 在孟德尔随机化假设下,遗传预测的CRP升高与精神分裂症风险降低相关,sIL-6R升高与风险增加相关,提示炎症通路可能参与精神分裂症风险。
  • 这些效应可能部分反映对早期生活感染的易感性增加,但需进一步研究验证。

局限性

  • 孟德尔随机化假设可能不满足,结果需谨慎解释。
  • 不同研究采用不同诊断程序,可能引入异质性。
  • 参与者主要为欧洲 ancestry 成年人,外推性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Positive associations between inflammatory biomarkers and risk of psychiatric disorders, including schizophrenia, have been reported in observational studies. However, conventional observational studies are prone to bias, such as reverse causation and residual confounding, thus limiting our understanding of the effect (if any) of inflammatory biomarkers on schizophrenia risk. OBJECTIVE: To evaluate whether inflammatory biomarkers have an effect on the risk of developing schizophrenia. DESIGN, SETTING, AND PARTICIPANTS: Two-sample mendelian randomization study using genetic variants associated with inflammatory biomarkers as instrumental variables to improve inference. Summary association results from large consortia of candidate gene or genome-wide association studies, including several epidemiologic studies with different designs, were used. Gene-inflammatory biomarker associations were estimated in pooled samples ranging from 1645 to more than 80 000 individuals, while gene-schizophrenia associations were estimated in more than 30 000 cases and more than 45 000 ancestry-matched controls. In most studies included in the consortia, participants were of European ancestry, and the prevalence of men was approximately 50%. All studies were conducted in adults, with a wide age range (18 to 80 years). EXPOSURES: Genetically elevated circulating levels of C-reactive protein (CRP), interleukin-1 receptor antagonist (IL-1Ra), and soluble interleukin-6 receptor (sIL-6R). MAIN OUTCOMES AND MEASURES: Risk of developing schizophrenia. Individuals with schizophrenia or schizoaffective disorders were included as cases. Given that many studies contributed to the analyses, different diagnostic procedures were used. RESULTS: The pooled odds ratio estimate using 18 CRP genetic instruments was 0.90 (random effects 95% CI, 0.84-0.97; P = .005) per 2-fold increment in CRP levels; consistent results were obtained using different mendelian randomization methods and a more conservative set of instruments. The odds ratio for sIL-6R was 1.06 (95% CI, 1.01-1.12; P = .02) per 2-fold increment. Estimates for IL-1Ra were inconsistent among instruments, and pooled estimates were imprecise and centered on the null. CONCLUSIONS AND RELEVANCE: Under mendelian randomization assumptions, our findings suggest a protective effect of CRP and a risk-increasing effect of sIL-6R (potentially mediated at least in part by CRP) on schizophrenia risk. It is possible that such effects are a result of increased susceptibility to early life infection.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Hartwig FP, Borges MC, Horta BL, et al. Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study. JAMA Psychiatry. 2017. PMID: 29094161. doi:10.1001/jamapsychiatry.2017.3191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。